Adeel Khan

746 citations

33 papers · 530 indexed · h-index 14

Co-authors: Zhiyang Li Kaili Di Tao Xiong Nongyue He Rongrong Huang Han Shen Su Wang Haroon Khan
Topics: Extracellular vesicles in disease (13 papers)MicroRNA in disease regulation (9 papers)Advanced biosensing and bioanalysis techniques (8 papers)
Cited by: Cancer Research Molecular Biology Biomedical Engineering
Journals: SHILAP Revista de lepidopterologíaFrontiers in Immunology Frontiers in Microbiology
Partner nations: China Pakistan United States

In The Last Decade

Adeel Khan

31 papers receiving 523 citations

Peers

Countries citing papers authored by Adeel Khan

Since Specialization

Citations

This map shows the geographic impact of Adeel Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adeel Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adeel Khan more than expected).

Fields of papers citing papers by Adeel Khan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adeel Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adeel Khan. The network helps show where Adeel Khan may publish in the future.

Co-authorship network of co-authors of Adeel Khan

This figure shows the co-authorship network connecting the top 25 collaborators of Adeel Khan. A scholar is included among the top collaborators of Adeel Khan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adeel Khan. Adeel Khan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Machine Learning-Based Identification of Novel Exosome-Derived Metabolic Biomarkers for the Diagnosis of Systemic Lupus Erythematosus and Differentiation of Renal Involvement 2025 ·Current Medical Science ·Zhongyu Wang,Wenjing Liu,(unknown),Xiaoshan Zhang,X. K. Chu,Adeel Khan,Shoubin Zhan,Han Shen,Ping Yang	1
2	Uncovering potential biomarkers and metabolic pathways in systemic lupus erythematosus and lupus nephritis through integrated microbiome and metabolome analysis 2025 ·BMC Microbiology ·Siyun Cheng,Xiaojie Chu,Zhongyu Wang,Adeel Khan,Yue Tao,Han Shen,Ping Yang	1
3	Identification of serum exosomal miRNA biomarkers in patients with lupus nephritis 2025 ·Clinical Rheumatology ·(unknown),Jia Gao,Bo Shi,Wenjing Liu,(unknown),Adeel Khan,Yifan Sun,Ping Yang,Zhiyang Li	2
4	Effect of Simple Oral Dental Extraction on Systemic Serum Amyloid A Concentrations in Horses 2024 ·Veterinary Medicine and Science ·(unknown),(unknown),Adeel Khan,(unknown),(unknown)	0
5	Unveiling Immune Infiltration Characterizing Genes in Hypertrophic Cardiomyopathy Through Transcriptomics and Bioinformatics 2024 ·Journal of Inflammation Research ·(unknown),Bo Shi,Ping Yang,Adeel Khan,(unknown),Zhiyang Li	4
6	Development of a Magnetically-Assisted SERS Biosensor for Rapid Bacterial Detection 2024 ·International Journal of Nanomedicine ·Siyun Cheng,Zhijie Tu,Shuai Zheng,Adeel Khan,Ping Yang,Han Shen,Bing Gu	13
7	Urinary microbiome profiling as a non-invasive tool for identifying biomarkers in systemic lupus erythematosus and lupus nephritis 2024 ·Frontiers in Cellular and Infection Microbiology ·Bo Shi,Fei Chen,(unknown),Adeel Khan,Qian Xiang,Zhipeng Xu,Ping Yang	2
8	Nanoscale Extracellular Vesicle-Enabled Liquid Biopsy: Advances and Challenges for Lung Cancer Detection 2024 ·Micromachines ·Adeel Khan,Faisal Raza,Nongyue He	3
9	Identification of serum exosomal miRNA biomarkers for diagnosis of Rheumatoid arthritis 2024 ·International Immunopharmacology ·(unknown),(unknown),Adeel Khan,Jun Liang,Tao Xiong,Ping Yang,Zhiyang Li	15
10	Fungal gut microbiota dysbiosis in systemic lupus erythematosus 2023 ·Frontiers in Microbiology ·Ping Yang,Rui Xu,Fei Chen,Shanshan Chen,Adeel Khan,Liang Li,Xiaoshan Zhang,Yanbo Wang,Zhipeng Xu,Han Shen	13
11	CRISPR-Cas and catalytic hairpin assembly technology for target-initiated amplification detection of pancreatic cancer specific tsRNAs 2023 ·Frontiers in Bioengineering and Biotechnology ·Jie Wu,Hongpan Xu,Fenghua Hu,(unknown),(unknown),Adeel Khan,Yifan Sun,Kaili Di,(unknown),Han Shen,Zhiyang Li	7
12	Signal-off electrochemical sensor for matrix metalloproteinase 9 detection based on sacrificial FeMOF and host-guest strategy 2023 ·Biosensors and Bioelectronics ·(unknown),Wenting Cheng,(unknown),Xiaoyue Li,Adeel Khan,(unknown),Jinlong Li	14
13	Clustered Regularly Interspaced Short Palindromic Repeats-Associated Proteins13a combined with magnetic beads, chemiluminescence and reverse transcription-recombinase aided amplification for detection of avian influenza a (H7N9) virus 2023 ·Frontiers in Bioengineering and Biotechnology ·Hongpan Xu,Lijun Peng,Jie Wu,Adeel Khan,Yifan Sun,Han Shen,Zhiyang Li	5
14	MicroRNAs: The next generation of cancer biomarkers 2023 ·Adeel Khan,Haroon Khan,(unknown),(unknown),Muhammad Waseem Khan,(unknown),(unknown),Mushtaq Ahmad,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	0
15	MicroRNAs in extracellular vesicles: Sorting mechanisms, diagnostic value, isolation, and detection technology 2022 ·Frontiers in Bioengineering and Biotechnology ·(unknown),Kaili Di,(unknown),Jie Wu,Xinrui Gu,Yifan Sun,Adeel Khan,Peng Li,Zhiyang Li	78
16	Exosomes based advancements for application in medical aesthetics 2022 ·Frontiers in Bioengineering and Biotechnology ·(unknown),(unknown),Lei He,Adeel Khan,Tao Xiong,Han Shen,Zhiyang Li	36
17	Plant-derived Ca, N, S-Doped carbon dots for fast universal cell imaging and intracellular Congo red detection 2022 ·Analytica Chimica Acta ·Samran Durrani,Jie Zhang,(unknown),Aiping Pang,Jia Zeng,Sayed Mir Sayed,Adeel Khan,Yaqin Zhang,Fu‐Gen Wu,Fengming Lin	31
18	A novel peptide-templated AgNPs nanoprobe for theranostics of prostate cancer 2022 ·Biosensors and Bioelectronics ·Wenting Cheng,Ying Sun,Guiping Zhao,Adeel Khan,Jianchun Zhang,Zhaoli Zhang,(unknown),(unknown),Jinlong Li	25
19	Highly efficient and automated isolation technology for extracellular vesicles microRNA 2022 ·Frontiers in Bioengineering and Biotechnology ·Kaili Di,(unknown),Xinrui Gu,Rongrong Huang,Adeel Khan,(unknown),Han Shen,Zhiyang Li	9
20	CRISPR-Cas13a mediated nanosystem for attomolar detection of canine parvovirus type 2 2019 ·Chinese Chemical Letters ·Haroon Khan,Adeel Khan,Yufeng Liu,Su Wang,(unknown),Hongpan Xu,Yuan Liu,Samran Durrani,Lian Jin,Nongyue He,Tao Xiong	53

About Adeel Khan

Adeel Khan is a scholar working on Cancer Research, Equine and Rheumatology, having authored 33 papers that have together received 530 indexed citations. Recurring topics across this work include Extracellular vesicles in disease (13 papers), MicroRNA in disease regulation (9 papers) and Advanced biosensing and bioanalysis techniques (8 papers). The work is most often cited by research in Cancer Research (136 citations), Molecular Biology (379 citations) and Biomedical Engineering (125 citations). Adeel Khan has collaborated with scholars based in China, Pakistan and United States. Frequent co-authors include Zhiyang Li, Kaili Di, Tao Xiong, Nongyue He, Rongrong Huang, Han Shen, Su Wang, Haroon Khan, Hongpan Xu and Shiyi Ye. Their work appears in journals such as SHILAP Revista de lepidopterología, Frontiers in Immunology and Frontiers in Microbiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact